Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Multidrug-resistant Tuberculosis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00727844
What this trial is testing

Linezolid to Treat Extensively-Drug Resistant Tuberculosis

Who this might be right for
Pulmonary TuberculosisMultidrug Resistant TuberculosisExtensively Drug Resistant Tuberculosis
National Institute of Allergy and Infectious Diseases (NIAID) 41
Not applicableLooking for participantsNCT05022238
What this trial is testing

Hotspots, Households and Hospitals: Enhanced Drug-resistant Tuberculosis Case Finding in Namibia

Who this might be right for
Tuberculosis, Multidrug-Resistant
University of Namibia 2,100
Large-scale testing (Phase 3)Study completedNCT01424670
What this trial is testing

Safety and Efficacy Trial of Delamanid for 6 Months in Participants With Multidrug-resistant Tuberculosis

Who this might be right for
Multidrug-resistant Tuberculosis
Otsuka Pharmaceutical Development & Commercialization, Inc. 511
Not applicableStudy completedNCT01618422
What this trial is testing

Directly Observed Therapy Short Course-Plus Versus DOTS for Retreatment of Relapsed Pulmonary Tuberculosis in Guangzhou

Who this might be right for
Pulmonary Tuberculosis
Chinese University of Hong Kong 225
Not applicableEnded earlyNCT04783727
What this trial is testing

PredictEndTB Signature for Individualizing Treatment in Multidrug-Resistant Tuberculosis

Who this might be right for
Tuberculosis, PulmonaryTuberculosis, Multidrug-ResistantBacterial Infections+1 more
Research Center Borstel 4
Large-scale testing (Phase 3)Study completedNCT03086486
What this trial is testing

Various Doses and Durations of Linezolid Plus Bedaquiline & Pretomanid in Participants With Drug Resistant Tuberculosis

Who this might be right for
Tuberculosis, PulmonaryTuberculosis, Multidrug-ResistantTuberculosis, MDR+4 more
Global Alliance for TB Drug Development 181
Post-approval studies (Phase 4)Looking for participantsNCT05381194
What this trial is testing

BPaL(M) Regimen for the Treatment of MDR/RR-TB

Who this might be right for
Multidrug- and Rifampicin-resistant Tuberculosis
Asan Medical Center 80
Large-scale testing (Phase 3)Ended earlyNCT01055145
What this trial is testing

Comparison of the Effect Between Levofloxacin and Moxifloxacin Among MDR-TB Patients

Who this might be right for
TB
Seoul National University Hospital 182
Not applicableStudy completedNCT03303963
What this trial is testing

DIAgnostics for Multidrug Resistant Tuberculosis in Africa

Who this might be right for
Tuberculosis, Multidrug-Resistant
Dissou AFFOLABI 3,356
Not applicableStudy completedNCT02234908
What this trial is testing

Rewards for Tuberculosis Contact Screening

Who this might be right for
TuberculosisDrug-resistant Tuberculosis
Boston University 301
Not applicableUnknownNCT02245347
What this trial is testing

Genome Sequencing of Multidrug Resistant Tuberculosis (MDR TB) in Sputum

Who this might be right for
Tuberculosis
St George's Healthcare NHS Trust 50
Post-approval studies (Phase 4)Looking for participantsNCT07477119
What this trial is testing

Linezolid Tolerance During the BPaL Regimen With Dosage Personalization Based on Therapeutic Drug Monitoring (TDM) During Multidrug-Resistant Tuberculosis Treatment

Who this might be right for
LinezolidTuberculosis Multi Drug Resistant ActiveTherapeutic Drug Monitoring (TDM)
Marco Schiuma 150
Post-approval studies (Phase 4)Looking for participantsNCT05493267
What this trial is testing

A Exploratory Study of Vγ2Vδ2 T Lymphocyte-based Immunotherapy for MDR-TB

Who this might be right for
MDR-TBImmunotherapy
Shanghai Pulmonary Hospital, Shanghai, China 30
Large-scale testing (Phase 3)Study completedNCT02409290
What this trial is testing

The Evaluation of a Standard Treatment Regimen of Anti-tuberculosis Drugs for Patients With MDR-TB

Who this might be right for
MDR-TB
IUATLD, Inc 588
Large-scale testing (Phase 3)Active Not RecruitingNCT06649721
What this trial is testing

Innovating Shorter, All- Oral, Precised Treatment Regimen for Rifampicin Resistant Tuberculosis：BDLL Chinese Cohort

Who this might be right for
Drug-resistant TuberculosisPulmonary TuberculosisRifampin-resistant Tuberculosis
Huashan Hospital 120
Not applicableStudy completedNCT03137875
What this trial is testing

Evaluation of PCR Using DNA Extract From Slides and Filter Paper for the Detection of Tuberculosis and MDR-tuberculosis

Who this might be right for
TuberculosisMulti Drug Resistant Tuberculosis
Epicentre 122
Not applicableStudy completedNCT02597621
What this trial is testing

Biomarkers for Therapy Response in Drug-resistant Tuberculosis

Who this might be right for
Tuberculosis, Multidrug-resistant
Research Center Borstel 192
Not applicableStudy completedNCT07003581
What this trial is testing

Cardiometabolic Risk Factors Associated With Multidrug-Resistant Tuberculosis

Who this might be right for
Tuberculosis (TB)
B.P. Koirala Institute of Health Sciences 183
Not applicableUnknownNCT02496572
What this trial is testing

Effectiveness of a Simplified Short Regimen for Multidrug Resistant Tuberculosis in Uzbekistan

Who this might be right for
Multidrug Resistant Tuberculosis
Medecins Sans Frontieres, Netherlands 110
Large-scale testing (Phase 3)Looking for participantsNCT07486024
What this trial is testing

Feasibility of the Application of a New Six-month Treatment for Multidrug-resistant Tuberculosis (MDR-TB) Patients in France (FAST-MDR)

Who this might be right for
MDR-TBTuberculosis Multi Drug Resistant ActiveAntibiotic Resistance+1 more
Assistance Publique - Hôpitaux de Paris 55
Next Page